A Single Blind, Randomised, Multi-centre, Active Controlled, Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of Ceftazidime and Avibactam When Given in Combination With Metronidazole, Compared With Meropenem, in Children From 3 Months to Less Than 18 Years of Age With Complicated Intra-Abdominal Infections (cIAIs)